Posted in General Business 30+ days ago.
Type: Full-Time
Business Account Executive, ONPATTRO: Torrance, CA
Overview
Alnylam is the world's leading RNA interference (RNAi) company.
Founded in 2002, Alnylam was built upon a bold vision of turning scientific possibility into reality by harnessing the power of RNAi for human health as an innovative new class of medicines. We are a growing biopharmaceutical company with three approved medicines and a robust pipeline of investigational medicines focused in four strategic therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases, including several in late-stage development.
Headquartered in Cambridge, Mass., Alnylam employs over 1,500 people in 19 countries and is rapidly growing globally, with additional offices in Norton, Mass., Maidenhead, U.K., Zug, Switzerland, Amsterdam, Netherlands, and Tokyo, Japan. Alnylam is proud to have been recognized as one of The Boston Globe's Top Places to Work six years in a row (2015-2020), a Great Place to Work in the U.K. and Switzerland two years in a row (2019-2020) and a Science Magazine's Top Employer two years in a row (2019-2020). Please visit www.alnylam.com for more information.
We are looking for experienced Business Account Executives (BAEs) with rare disease experience to promote ONPATTRO (patisiran) in the U.S. ONPATTRO was approved in August 2018 by the FDA for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) in adults. The successful candidate will also have the opportunity to be part of the sales team responsible for the potential launch and commercialization of Alnylam's second therapeutic in Alnylam's TTR portfolio. Vutrisiran is currently under review by the FDA for the treatment of the polyneuropathy of hATTR amyloidosis. hATTR amyloidosis is a little-known condition in the United States and patients often spend years undiagnosed and misdiagnosed. There is an amazing opportunity to educate and enhance the market's knowledge of hATTR amyloidosis.
The ONPATTRO BAE (ON BAE) will be principally responsible for driving physician and patient identification, disease awareness, overall market development, and brand awareness within their ascribed territory. The BAE will be responsible for achieving territory targets and other business objectives through account and customer strategies, while also partnering & collaborating very closely with internal and external stakeholders to effectively manage all aspects of the regional business. The achievement of targets will be based in Alnylam values: our commitment to people, sense of urgency, passion for excellence, innovation & discovery, and open culture as well as our unwavering commitment to integrity.
The position reports into the ONPATTRO (ON) Regional Business Director.
Summary of Key Responsibilities
Wells Fargo |
Roth Staffing Companies |
Volcom |
Targa Resources
$80,000.00 - $93,000.00 per year
|
Hilton Global |
Samuel, Son & Co. (USA) Inc. |